Literature DB >> 30114941

Progressive Massive Fibrosis Resurgence Identified in U.S. Coal Miners Filing for Black Lung Benefits, 1970-2016.

Kirsten S Almberg1,2, Cara N Halldin2, David J Blackley2, A Scott Laney2, Eileen Storey2, Cecile S Rose3, Leonard H T Go1, Robert A Cohen1,2.   

Abstract

RATIONALE: There has been a resurgence of progressive massive fibrosis (PMF) in the United States, particularly among central Appalachian miners.
OBJECTIVES: We characterized the proportion of PMF among former U.S. coal miners applying for Federal Black Lung Program benefits, 1970-2016.
METHODS: Data from the U.S. Department of Labor were used to characterize trends in proportion of PMF cases, defined as an approved black lung claim with a determination of PMF, among all miners who filed for federal benefits between January 1, 1970, and December 31, 2016. Joinpoint, logistic, and linear regression models were used to identify changes in the proportion of claimants with PMF over time.
RESULTS: There were 4,679 unique PMF cases among claimants for federal black lung benefits between 1970 and 2016, with 2,474 miners determined to have PMF since 1996. The number of PMF cases among Federal Black Lung Program claimants fell from 404 (0.5% of claimants) in 1978 to a low of 18 cases (0.6%) in 1988, and then increased to 353 cases (8.3%) in 2014. The proportion of federal black lung benefits claimants with PMF has been increasing since 1978 (0.06% annual percent change [APC]; 95% confidence interval [CI], 0.05-0.07%; P < 0.0001), and began increasing at a significantly increased rate after 1996 (0.26% APC; 95% CI, 0.25-0.28%; P < 0.0001). Most miners with PMF (84%) last mined in West Virginia, Kentucky, Pennsylvania, or Virginia. Since 1970, the proportion of claimants with PMF has increased significantly among miners who last worked in Kentucky (16.6% APC; 95% CI, 16.5-16.7%), Pennsylvania (4.7% APC; 95% CI, 4.6-4.8%), Tennessee (16.1% APC; 95% CI, 15.7-16.4%), West Virginia (16.8% APC; 95% CI, 16.6-16.9%), and most sharply among miners last working in Virginia (31.5% APC; 95% CI, 31.2-31.7%), where in 2009, more than 17% of claimants received a PMF determination. The proportion of PMF determinations for the rest of the United States has not exceeded 4%.
CONCLUSIONS: There has been a resurgence of PMF, particularly in central Appalachian miners. The resurgence of this preventable disease points to the need for improved primary and secondary prevention of dust-related lung disease in U.S. coal miners.

Entities:  

Keywords:  black lung benefits; coal mine dust; coal workers’ pneumoconiosis; progressive massive fibrosis

Mesh:

Year:  2018        PMID: 30114941      PMCID: PMC6528482          DOI: 10.1513/AnnalsATS.201804-261OC

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN: 2325-6621


  24 in total

1.  Permutation tests for joinpoint regression with applications to cancer rates.

Authors:  H J Kim; M P Fay; E J Feuer; D N Midthune
Journal:  Stat Med       Date:  2000-02-15       Impact factor: 2.373

2.  Pneumoconiosis prevalence among working coal miners examined in federal chest radiograph surveillance programs--United States, 1996-2002.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2003-04-18       Impact factor: 17.586

3.  Advanced cases of coal workers' pneumoconiosis--two counties, Virginia, 2006.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2006-08-25       Impact factor: 17.586

4.  Mortality among U.S. underground coal miners: a 23-year follow-up.

Authors:  M D Attfield; E D Kuempel
Journal:  Am J Ind Med       Date:  2008-04       Impact factor: 2.214

5.  Coal workers' pneumoconiosis in the United States: regional differences 40 years after implementation of the 1969 Federal Coal Mine Health and Safety Act.

Authors:  Eva Suarthana; A Scott Laney; Eileen Storey; Janet M Hale; Michael D Attfield
Journal:  Occup Environ Med       Date:  2011-05-19       Impact factor: 4.402

6.  Debilitating lung disease among surface coal miners with no underground mining tenure.

Authors:  Cara N Halldin; William R Reed; Gerald J Joy; Jay F Colinet; James P Rider; Edward L Petsonk; Jerrold L Abraham; Anita L Wolfe; Eileen Storey; A Scott Laney
Journal:  J Occup Environ Med       Date:  2015-01       Impact factor: 2.162

7.  Comparative Respiratory Morbidity of Former and Current US Coal Miners.

Authors:  Cara N Halldin; Anita L Wolfe; A Scott Laney
Journal:  Am J Public Health       Date:  2015-10-15       Impact factor: 9.308

8.  The accuracy of self-reported regulatory data: the case of coal mine dust.

Authors:  L I Boden; M Gold
Journal:  Am J Ind Med       Date:  1984       Impact factor: 2.214

9.  Exposure-response analysis of mortality among coal miners in the United States.

Authors:  E D Kuempel; L T Stayner; M D Attfield; C R Buncher
Journal:  Am J Ind Med       Date:  1995-08       Impact factor: 2.214

10.  Lung-function impairment among US underground coal miners, 2005 to 2009: geographic patterns and association with coal workers' pneumoconiosis.

Authors:  Mei Lin Wang; Lu-Ann Beeckman-Wagner; Anita L Wolfe; Girija Syamlal; Edward L Petsonk
Journal:  J Occup Environ Med       Date:  2013-07       Impact factor: 2.162

View more
  12 in total

1.  Patterns of progressive massive fibrosis on modern coal miner chest radiographs.

Authors:  Cara N Halldin; David J Blackley; Travis Markle; Robert A Cohen; A Scott Laney
Journal:  Arch Environ Occup Health       Date:  2019-05-20       Impact factor: 1.663

2.  Continued increase in prevalence of r-type opacities among underground coal miners in the USA.

Authors:  Noemi B Hall; David J Blackley; Cara N Halldin; A Scott Laney
Journal:  Occup Environ Med       Date:  2019-04-25       Impact factor: 4.402

Review 3.  Current Review of Pneumoconiosis Among US Coal Miners.

Authors:  Noemi B Hall; David J Blackley; Cara N Halldin; A Scott Laney
Journal:  Curr Environ Health Rep       Date:  2019-09

4.  A systematic review and meta-analysis on international studies of prevalence, mortality and survival due to coal mine dust lung disease.

Authors:  Cynthia Lu; Paramita Dasgupta; Jessica Cameron; Lin Fritschi; Peter Baade
Journal:  PLoS One       Date:  2021-08-03       Impact factor: 3.240

5.  Silica Induced Lung Fibrosis Is Associated With Senescence, Fgr, and Recruitment of Bone Marrow Monocyte/Macrophages.

Authors:  Amitava Mukherjee; Michael W Epperly; Renee Fisher; Wen Hou; Donna Shields; Hong Wang; Joel S Greenberger; Luis A Ortiz
Journal:  In Vivo       Date:  2021 Nov-Dec       Impact factor: 2.155

6.  High-fat western diet-consumption alters crystalline silica-induced serum adipokines, inflammatory cytokines and arterial blood flow in the F344 rat.

Authors:  Janet A Thompson; Kristine Krajnak; Richard A Johnston; Michael L Kashon; Walter McKinney; Jeffrey S Fedan
Journal:  Toxicol Rep       Date:  2021-12-07

7.  Computed Tomography Findings in Progressive Massive Fibrosis: Analyses of 90 Cases.

Authors:  Gülden Sarı; Atila Gökçek; Adem Koyuncu; Cebrail Şimşek
Journal:  Med Lav       Date:  2022-02-22       Impact factor: 1.275

Review 8.  Current global perspectives on silicosis-Convergence of old and newly emergent hazards.

Authors:  Ryan F Hoy; Mohamed F Jeebhay; Catherine Cavalin; Weihong Chen; Robert A Cohen; Elizabeth Fireman; Leonard H T Go; Antonio León-Jiménez; Alfredo Menéndez-Navarro; Marcos Ribeiro; Paul-André Rosental
Journal:  Respirology       Date:  2022-03-18       Impact factor: 6.175

9.  Respirable coal mine dust at surface mines, United States, 1982-2017.

Authors:  Brent C Doney; David Blackley; Janet M Hale; Cara Halldin; Laura Kurth; Girija Syamlal; A Scott Laney
Journal:  Am J Ind Med       Date:  2019-12-09       Impact factor: 3.079

Review 10.  Respiratory surveillance for coal mine dust and artificial stone exposed workers in Australia and New Zealand: A position statement from the Thoracic Society of Australia and New Zealand.

Authors:  Jennifer L Perret; Susan Miles; Fraser Brims; Katrina Newbigin; Maggie Davidson; Hubertus Jersmann; Adrienne Edwards; Graeme Zosky; Anthony Frankel; Anthony R Johnson; Ryan Hoy; David W Reid; A William Musk; Michael J Abramson; Bob Edwards; Robert Cohen; Deborah H Yates
Journal:  Respirology       Date:  2020-10-13       Impact factor: 6.424

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.